Implantable cardioverter defibrillators (ICDs) are associated with improved survival among heart failure patients whose left ventricles only pump 30 to 35 percent of blood out of the heart with each contraction, according to a study from the Duke Clinical Research Institute.
The findings, published in the June 4 issue of the Journal of the American Medical Association, support existing recommendations to implant ICDs in patients with a left ventricular ejection fraction (LVEF) – a measurement of how much blood is squeezed out of the heart – of 35 percent or lower.
"Our findings fill an important gap in knowledge, as most randomized clinical trials of ICDs include heart failure patients with a median LVEF of well below 30 percent," said Sana Al-Khatib, M.D., MHS, the study's lead investigator and associate professor of medicine at Duke.
"Given that a large number ICDs are implanted in patients with a LVEF between 30 to 35 percent, understanding outcomes in such patients is important."
ICDs are small devices implanted in the chest to monitor the heart's rhythm and deliver small electrical pulses or shocks to help treat life-threatening heart rhythm disorders. Previous clinical trials have shown that ICDs are the best therapy currently available to prevent sudden cardiac death in patients with heart failure.
The researchers found that survival of heart failure patients with a LVEF of 30 to 35 percent was significantly improved in those with ICDs versus those without ICDs. Three-year mortality rates dropped from 55 percent to 51.4 percent when an ICD was implanted.
Similarly, ICDs were associated with increased survival among heart failure patients with a LVEF of less than 30 percent, with three-year mortality rates dropping from 57.6 percent to 45 percent with ICD use.
Joint guidelines from the American College of Cardiology Foundation and the American Heart Association recommend using ICDs to prevent sudden cardiac death in select patients with a LVEF of 35 percent or less. The American College of Cardiology defines a normal heart's LVEF as 50 to 70 percent, while a measurement below 50 percent may be a sign of dysfunction or heart failure.
To better understand outcomes among heart failure patients with a LVEF of 30 to 35 percent, the researchers studied the National Cardiovascular Data Registry, intended to track primary prevention ICDs implanted in Medicare beneficiaries, making it the largest repository of ICD implants in the United States. They compared individuals in the registry with heart failure patients in the Get With the Guidelines-Heart Failure database who also had a LVEF of 30 to 35 percent but did not have ICDs.
The researchers compared all-cause mortality among those with and without ICDs, looking at a total of 3,120 patients with a LVEF of 30 to 35 percent. The analysis was repeated in 4,578 patients with a LVEF of less than 30 percent.
"Until now, the association between the ICD and improved outcomes in patients with a LVEF of 30 to 35 percent was largely implied," Al-Khatib said. "Our results support current guidelines to implant prophylactic ICDs in patients with a LVEF of 35 percent or lower."
Explore further: Remotely monitoring heart patients with implanted defibrillators lowers risk of death
More information: Paper doi:10.1001/jama.2014.5310
Medical Xpress on facebook
Related Stories
Remotely monitoring heart patients with implanted defibrillators lowers risk of death
May 12, 2014
(Medical Xpress)—Patients with implantable cardioverter defibrillators (ICD) have significantly lower risk of death and re-hospitalization if they are followed through an automatic, wireless remote monitoring ...
Cardiac resynchronization improves survival in heart failure patients
Mar 31, 2014
Patients in mild heart failure who receive a specialized pacemaker known as cardiac resynchronization therapy with a defibrillator (CRT-D) may live longer than those implanted with a traditional implantable cardioverter defibrillator ...
Elderly benefit from using implantable defibrillators
Jun 17, 2013
The elderly may benefit from implantable cardioverter defibrillators as much as younger people, according to new research in the American Heart Association journal Circulation.
ICDs can reduce sudden death in young patients with hypertrophic cardiomyopathy
Nov 05, 2012
A multicenter registry has demonstrated that the use of implantable cardioverter-defibrillators (ICDs) to combat sudden cardiac death in high-risk pediatric patients suffering from hypertrophic cardiomyopathy (HCM). The study ...
Are ICDs up to par with patients living longer?
Apr 04, 2011
Most patients with ischemic cardiomyopathy (ICM) and dilated cardiomyopathy (DCM) who have an implantable cardioverter-defibrillator (ICD) now live more than seven years and those ICD patients with hereditary heart disease ...
Recommended for you
Community program helps lower blood pressure among minorities
2 seconds ago
Minorities at a higher risk of developing hypertension used a community-based program to significantly lower their blood pressure, researchers said at the American Heart Association's Quality of Care and Outcomes Research ...
Many breast cancer patients don't get treatment for heart problems
2 seconds ago
Only a third of older breast cancer patients saw a cardiologist within 90 days of developing heart problems, in a study presented at the American Heart Association's Quality of Care and Outcomes Research 2014 Scientific Sessions.
Beta-blockers have no impact on cocaine-related chest pain
42 minutes ago
(HealthDay)—For patients with cocaine-associated chest pain, there are no differences in outcome for those treated with or without β-blockers, according to a study published in the June 1 issue of The Am ...
How long is too long to wait for groundbreaking aortic valve replacement surgery?
2 hours ago
Severe aortic stenosis (AS) has a grave prognosis with 25-50% of patients dying within a year once symptoms develop. Transcatheter aortic valve replacement (TAVR) represents a paradigm shift in the therapeutic options for ...
More than 10 percent of heart attack patients may have undiagnosed diabetes
4 hours ago
At least 10 percent of people who have a heart attack may have undiagnosed diabetes, according to new research presented at the American Heart Association's Quality of Care and Outcomes Research Scientific Sessions 2014.
Chinese stroke patients fare better when hospitals follow guidelines
4 hours ago
Chinese stroke patients were less likely to acquire pneumonia or die from the stroke when hospitals followed treatment guidelines, according to research presented at the American Heart Association's Quality of Care and Outcomes ...
User comments
© Medical Xpress 2011-2014, Science X network
Implantable cardioverter defibrillators (ICDs) are associated with improved survival among heart failure patients whose left ventricles only pump 30 to 35 percent of blood out of the heart with each contraction, according to a study from the Duke Clinical Research Institute.
The findings, published in the June 4 issue of the Journal of the American Medical Association, support existing recommendations to implant ICDs in patients with a left ventricular ejection fraction (LVEF) – a measurement of how much blood is squeezed out of the heart – of 35 percent or lower.
"Our findings fill an important gap in knowledge, as most randomized clinical trials of ICDs include heart failure patients with a median LVEF of well below 30 percent," said Sana Al-Khatib, M.D., MHS, the study's lead investigator and associate professor of medicine at Duke.
"Given that a large number ICDs are implanted in patients with a LVEF between 30 to 35 percent, understanding outcomes in such patients is important."
ICDs are small devices implanted in the chest to monitor the heart's rhythm and deliver small electrical pulses or shocks to help treat life-threatening heart rhythm disorders. Previous clinical trials have shown that ICDs are the best therapy currently available to prevent sudden cardiac death in patients with heart failure.
The researchers found that survival of heart failure patients with a LVEF of 30 to 35 percent was significantly improved in those with ICDs versus those without ICDs. Three-year mortality rates dropped from 55 percent to 51.4 percent when an ICD was implanted.
Similarly, ICDs were associated with increased survival among heart failure patients with a LVEF of less than 30 percent, with three-year mortality rates dropping from 57.6 percent to 45 percent with ICD use.
Joint guidelines from the American College of Cardiology Foundation and the American Heart Association recommend using ICDs to prevent sudden cardiac death in select patients with a LVEF of 35 percent or less. The American College of Cardiology defines a normal heart's LVEF as 50 to 70 percent, while a measurement below 50 percent may be a sign of dysfunction or heart failure.
To better understand outcomes among heart failure patients with a LVEF of 30 to 35 percent, the researchers studied the National Cardiovascular Data Registry, intended to track primary prevention ICDs implanted in Medicare beneficiaries, making it the largest repository of ICD implants in the United States. They compared individuals in the registry with heart failure patients in the Get With the Guidelines-Heart Failure database who also had a LVEF of 30 to 35 percent but did not have ICDs.
The researchers compared all-cause mortality among those with and without ICDs, looking at a total of 3,120 patients with a LVEF of 30 to 35 percent. The analysis was repeated in 4,578 patients with a LVEF of less than 30 percent.
"Until now, the association between the ICD and improved outcomes in patients with a LVEF of 30 to 35 percent was largely implied," Al-Khatib said. "Our results support current guidelines to implant prophylactic ICDs in patients with a LVEF of 35 percent or lower."
Explore further: Remotely monitoring heart patients with implanted defibrillators lowers risk of death
More information: Paper doi:10.1001/jama.2014.5310
Medical Xpress on facebook
Related Stories
Remotely monitoring heart patients with implanted defibrillators lowers risk of death
May 12, 2014
(Medical Xpress)—Patients with implantable cardioverter defibrillators (ICD) have significantly lower risk of death and re-hospitalization if they are followed through an automatic, wireless remote monitoring ...
Cardiac resynchronization improves survival in heart failure patients
Mar 31, 2014
Patients in mild heart failure who receive a specialized pacemaker known as cardiac resynchronization therapy with a defibrillator (CRT-D) may live longer than those implanted with a traditional implantable cardioverter defibrillator ...
Elderly benefit from using implantable defibrillators
Jun 17, 2013
The elderly may benefit from implantable cardioverter defibrillators as much as younger people, according to new research in the American Heart Association journal Circulation.
ICDs can reduce sudden death in young patients with hypertrophic cardiomyopathy
Nov 05, 2012
A multicenter registry has demonstrated that the use of implantable cardioverter-defibrillators (ICDs) to combat sudden cardiac death in high-risk pediatric patients suffering from hypertrophic cardiomyopathy (HCM). The study ...
Are ICDs up to par with patients living longer?
Apr 04, 2011
Most patients with ischemic cardiomyopathy (ICM) and dilated cardiomyopathy (DCM) who have an implantable cardioverter-defibrillator (ICD) now live more than seven years and those ICD patients with hereditary heart disease ...
Recommended for you
Community program helps lower blood pressure among minorities
2 seconds ago
Minorities at a higher risk of developing hypertension used a community-based program to significantly lower their blood pressure, researchers said at the American Heart Association's Quality of Care and Outcomes Research ...
Many breast cancer patients don't get treatment for heart problems
2 seconds ago
Only a third of older breast cancer patients saw a cardiologist within 90 days of developing heart problems, in a study presented at the American Heart Association's Quality of Care and Outcomes Research 2014 Scientific Sessions.
Beta-blockers have no impact on cocaine-related chest pain
42 minutes ago
(HealthDay)—For patients with cocaine-associated chest pain, there are no differences in outcome for those treated with or without β-blockers, according to a study published in the June 1 issue of The Am ...
How long is too long to wait for groundbreaking aortic valve replacement surgery?
2 hours ago
Severe aortic stenosis (AS) has a grave prognosis with 25-50% of patients dying within a year once symptoms develop. Transcatheter aortic valve replacement (TAVR) represents a paradigm shift in the therapeutic options for ...
More than 10 percent of heart attack patients may have undiagnosed diabetes
4 hours ago
At least 10 percent of people who have a heart attack may have undiagnosed diabetes, according to new research presented at the American Heart Association's Quality of Care and Outcomes Research Scientific Sessions 2014.
Chinese stroke patients fare better when hospitals follow guidelines
4 hours ago
Chinese stroke patients were less likely to acquire pneumonia or die from the stroke when hospitals followed treatment guidelines, according to research presented at the American Heart Association's Quality of Care and Outcomes ...
User comments
© Medical Xpress 2011-2014, Science X network
0 comments:
Post a Comment